Open AccessAn optimized nested polymerase chain reaction (PCR) approach allows detection and characterization of human immunodeficiency virus type 1 (HIV‐1) env and gag genes from clinical samples
Author(s) -
Locateli Dayse,
Stoco Patricia H.,
Zanetti Carlos R.,
Pinto Aguinaldo R.,
Grisard Edmundo C.
Publication year - 2008
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.20229
Subject(s) - group specific antigen , polymerase chain reaction , virology , virus , gene , biology , nested polymerase chain reaction , typing , dna , human immunodeficiency virus (hiv) , polymerase , microbiology and biotechnology , genetics
The needs for development and/or improvement of molecular approaches for microorganism detection and characterization such as polymerase chain reaction (PCR) are of high interest due their sensitivity and specificity when compared to traditional microbiological techniques. Considering the worldwide importance of human immunodeficiency virus type 1 (HIV‐1) infection, it is essential that such approaches consider the genetic variability of the virus, the heterogeneous nature of the clinical samples, the existence of contaminants and inhibitors, and the consequent needs for standardization in order to guarantee the reproducibility of the methods. In this work we describe a nested PCR assay targeting HIV‐1 virus gag and env genes, allowing specific and sensitive diagnosis and further direct characterization of clinical samples. The method described herein was tested on clinical samples and allowed the detection of HIV‐1 presence in all samples tested for the gag gene and 90.9% for the env gene, revealing sensitivities of 1 fg and 100 fg, respectively. Also, no cross‐reactions were observed with DNA from infected and noninfected patients and the method allowed detection of the env and gag genes on an excess of 10 8 and 10 4 of human deoxyribonucleic acid (DNA), respectively. Furthermore, it was possible to direct sequence all amplified products, which allowed the sub typing of the virus in clinical samples. J. Clin. Lab. Anal. 22:106–113, 2008. © 2008 Wiley‐Liss, Inc.